During the past decade, Whiston Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whiston Hospital" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "University of Leeds" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Institute of Cancer Research, United Kingdom" with 1 trials sponsored and "Janssen-Cilag Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Whiston Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Whiston Hospital" are "Colitis, Ulcerative" (3 trials), "Multiple Myeloma" (2 trials), "Prostate Cancer" (2 trials), "Acute Coronary Syndromes" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Whiston Hospital" in a lesser frequency.

Most popular intervention types in "Whiston Hospital" are "Drug" (10 trials), "Other" (3 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "Spesolimab" (2 trials) and "ARB + DMX-200" (1 trials). Other intervention names were less common.

The vast majority of trials in "Whiston Hospital" are 13 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Whiston Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Whiston Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Whiston Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".